ESTRO 35 Programme book

> Gender and secondary malignancies in rectal cancer patients with and without radiation therapy R. Warschkow, U. Güller, T. Cerny, B.M. Schmied, L. Plasswilm, P.M. Putora (Switzerland) > Does daily intake of resistant starch reduce the acute bowel symptoms in pelvic radiotherapy? RCT B.K. Sasidharan (India), P.N. Viswanathan, S. Prasanna, B. Ramadass, S. Pugazhendhi, B.S. Ramakrishna > Chemoradiation+surgery vs chemoradiation+BRT in advanced cervical carcinoma: a case-control study S. Cima (Switzerland), G. Macchia, A. Galuppi, M. Nuzzo, P. De Iaco, F. Deodato, A.M. Perrone, M.C. Valli, A. Richetti, A. Arcelli, F. Bertini, A. Farioli, S. Cammelli, A. Bisceglie, M. Pieri, S.G. Picchi, A. Zamagni, G. Frezza, A.G. Morganti, G. Ferrandina

PD-0123

SATURDAY 30 APRIL 2016

PD-0124

PD-0125

MULTIDISCIPLINARY TUMOUR BOARD:SESSION 1: BREAST 14:30 - 15:45 | ISTANBUL Chair: A. Kirby (UK)

ESTRO fellow Panellist: D. Vordermark (Germany)

Clinical oncologist Panellist: B. Offersen (Denmark)

Radiologist Panellist: M. Durando (Italy)

Surgeon Panellist: R. Audisio (UK)

Joint Symposium ESTRO-ESR: MR-PET 16:30 - 17:30 | ROOM 2

Advanced radiotherapy recognises a crucial role to modern hybrid imaging techniques, which enrich the morphological tissue analysis with metabolic information. MR-PET imaging represents to date one of the most promising techniques in this scenario, offering the advantages of anatomical detail en- hancement, gain of morphological reliability, soft tissue contrast and multiparametric studies together with biological details obtained through the use of specific tracers describing molecular pathways from cell proliferation to hypoxia.

INTERDISCIPLINARY RADIOBIOLOGY

CLINICAL BRACHYTHERAPY PHYSICS

RTT

YOUNG

SCIENTIFIC PROGRAMME | PROGRAMME AND EXHIBITION GUIDE

78